Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1938 1
1947 1
1948 1
1950 1
1953 3
1954 6
1955 2
1956 2
1957 3
1958 5
1960 2
1961 1
1962 3
1963 10
1964 1
1965 2
1966 4
1967 2
1968 2
1969 4
1970 3
1971 3
1972 5
1973 4
1974 3
1975 2
1976 2
1977 1
1978 6
1979 4
1980 7
1981 4
1982 5
1983 11
1984 8
1985 6
1986 11
1987 5
1988 13
1989 8
1990 7
1991 7
1992 8
1993 7
1994 10
1995 10
1996 13
1997 12
1998 15
1999 15
2000 29
2001 22
2002 27
2003 35
2004 42
2005 68
2006 82
2007 50
2008 31
2009 31
2010 26
2011 33
2012 32
2013 30
2014 18
2015 25
2016 30
2017 22
2018 21
2019 42
2020 33
2021 20
Text availability
Article attribute
Article type
Publication date

Similar articles for PMID: 17332177

955 results
Results by year
Filters applied: . Clear all
Page 1
Safety and immunogenicity of concurrent administration of live attenuated influenza vaccine with measles-mumps-rubella and varicella vaccines to infants 12 to 15 months of age.
Nolan T, Bernstein DI, Block SL, Hilty M, Keyserling HL, Marchant C, Marshall H, Richmond P, Yogev R, Cordova J, Cho I, Mendelman PM; LAIV Study Group. Nolan T, et al. Pediatrics. 2008 Mar;121(3):508-16. doi: 10.1542/peds.2007-1064. Pediatrics. 2008. PMID: 18310199 Clinical Trial.
The safety and immunogenicity of a quadrivalent measles, mumps, rubella and varicella vaccine in healthy children: a study of manufacturing consistency and persistence of antibody.
Lieberman JM, Williams WR, Miller JM, Black S, Shinefield H, Henderson F, Marchant CD, Werzberger A, Halperin S, Hartzel J, Klopfer S, Schödel F, Kuter BJ; Consistency Lot Study Group for ProQuad. Lieberman JM, et al. Pediatr Infect Dis J. 2006 Jul;25(7):615-22. doi: 10.1097/01.inf.0000220209.35074.0b. Pediatr Infect Dis J. 2006. PMID: 16804432 Clinical Trial.
Immunogenicity and safety assessments after one and two doses of a refrigerator-stable tetravalent measles-mumps-rubella-varicella vaccine in healthy children during the second year of life.
Schuster V, Otto W, Maurer L, Tcherepnine P, Pfletschinger U, Kindler K, Soemantri P, Walther U, Macholdt U, Douha M, Pierson P, Willems P. Schuster V, et al. Pediatr Infect Dis J. 2008 Aug;27(8):724-30. doi: 10.1097/INF.0b013e318170bb22. Pediatr Infect Dis J. 2008. PMID: 18600190 Clinical Trial.
Immunogenicity and safety of two tetravalent (measles, mumps, rubella, varicella) vaccines coadministered with hepatitis a and pneumococcal conjugate vaccines to children twelve to fourteen months of age.
Blatter MM, Klein NP, Shepard JS, Leonardi M, Shapiro S, Schear M, Mufson MA, Martin JM, Varman M, Grogg S, London A, Cambron P, Douha M, Nicholson O, da Costa C, Innis BL. Blatter MM, et al. Pediatr Infect Dis J. 2012 Aug;31(8):e133-40. doi: 10.1097/INF.0b013e318259fc8a. Pediatr Infect Dis J. 2012. PMID: 22622699 Clinical Trial.
955 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page